Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Divestments Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances

Daily Values

Growth Metrics

Acadia Healthcare Company (ACHC) Acquisitions (2016 - 2025)

Acadia Healthcare Company (ACHC) has disclosed Acquisitions for 10 consecutive years, with -$429000.0 as the latest value for Q2 2025.

For Q2 2025, Acquisitions fell 216.26% year-over-year to -$429000.0; the TTM value through Dec 2025 reached $8.2 million, down 84.75%, while the annual FY2025 figure was $8.2 million, 84.75% down from the prior year.
Acquisitions hit -$429000.0 in Q2 2025 for Acadia Healthcare Company, down from $8.6 million in the prior quarter.
Across five years, Acquisitions topped out at $50.4 million in Q1 2024 and bottomed at -$429000.0 in Q2 2025.